InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
Drugmakers see stocks tank after RFK Jr is nominated to oversee health department
JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...
Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...
Armed robbery in Revesby2h
Why U.S. Will Remove Fluoride From Public Water
President-elect Donald Trump has announced plans to appoint Robert F. Kennedy Jr. as head of the U.S. Department of Health ...
Mediaite on MSN14h
CNN’s Kaitlan Collins Rips RFK Jr. ‘Lies’ After Trump Announces Pick — With Blizzard Of Clips
Kaitlan Collins tore apart Trump's selection of Robert F. Kennedy Jr. to lead the Department of Health and Human Services with a raft of damaging clips.
clinicaltrialsarena1d
Putting the DACH region on the map for clinical trials
At the OCT DACH conference, experts shared how EU laws, digitalisation, and more, are impacting trials in the DACH region and ...
manilatimes1d
Ascendis Pharma Reports Third Quarter 2024 Financial Results
For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...
stockhead4d
Dr Boreham’s Crucible: Transforming the cardiac ablation market takes ticker… and time
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ...
Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript
Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...